
Vertex Unveils New ALYFTREK® Data at European Cystic Fibrosis Conference
Vertex Highlights Promising ALYFTREK and TRIKAFTA Data in Young Children with Cystic Fibrosis at European Conference Vertex Pharmaceuticals has unveiled new clinical data demonstrating the potential of its next-generation cystic fibrosis (CF) therapies to further improve outcomes in young children…












